The variant has been detected in 20 people in 11 states so far, CNBC is reporting this morning. Caess have been detected inCalifornia, Colorado, Hawaii, Minnesota, New York, Maryland, Minnesota, Missouri, Nebraska, Pennsylvania, and Utah.
In pre-print published Thursday (Dec. 2) on medRxiv, a team of South African researchers led Juliet R.C. Pulliam reported that omicron variant can evade immunity from prior infection. They identified 35,670 suspected reinfections among 2,796,982 individuals with laboratory-confirmed SARS-CoV-2 who had a positive test result at least 90 days prior to Nov. 27,2021.
The researchers said it is still an open question whether the variant can get by immunological defenses primed by vaccination.
Here are the exact words in the conclusion of their abstract: “Population-level evidence suggests that the Omicron variant is associated with substantial ability to evade immunity from prior infection. In contrast, there is no population-wide epidemiological evidence of immune escape associated with the Beta or Delta variants. This finding has important implications for public health planning, particularly in countries like South Africa with high rates of immunity from prior infection. Urgent questions remain regarding whether Omicron is also able to evade vaccine-induced immunity and the potential implications of reduced immunity to infection on protection against severe disease and death.”
Research published on medRxiv has not been peer reviewed, so it comes with a blanket proviso that it is preliminary and subject to change.
President Biden announced in his press briefing at the National Institutes of Health on Thursday (Dec.2) that private health insurers will have to cover at-home COVID-19 states. The at-home tests include Abbott’s BinaxNOW, Ellume’s Covid-19 Home Test, and Quidel’s QuickVue. The administration is also gearing up to make the tests available at community health centers and rural health clinics. But one of the biggest problems is that the demand for the tests is overwhelming the limited supply.
CDC Director Rochelle Walensky said on Tuesday (Nov. 30) that federal health authorities are not changing the definition of “fully vaccinated” to include a booster shot yet. The current definition is vaccination with two doses of the Pfizer or Moderna vaccines or a single dose of the Johnson & Johnson vaccine.
But Walensky left the door ajar for revising the definition: “As that science evolves, we will look at whether we need to update our definition of ‘fully vaccinated,’” she said, according to Kaiser Health News.
Ashish Jha, M.D., M.P.H., dean of the Brown University School of Public Health, has become a leading voice on the pandemic. In an interview with Newsmax, the conservative media outlet yesterday (Dec. 3) morning, Jha said omicron variant had not changed the public health advice: “People should get vaccinated,” he said during a morning show interviews. “If you have been previously infected and recovered you should still get vaccinated because the evidence suggests that hybrid immunity of someone who has been previously infected and gets vaccinated is really the best of all. I think people six months out should get a booster. That to me is the evidence of what it is going to take as the primary way we are going to get out of this pandemic. We’ll see what omicron throws at us. But I don’t think it is going to change the game.”
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More